An Octakis-intercalating molecule

Bioorganic and Medicinal Chemistry

Volumn 9, Issue 5, 2001, Pages 1141-1148

  Murr, Meredith M ^a   Harting, Matthew T ^a   Guelev, Vladimir ^a   Ren, Jinsong ^b   Chaires, Jonathan B ^b   Iverson, Brent L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,5,8 NAPTHALENETETRACARBOXYLIC DIIMIDE DERIVATIVE; BACTERIAL DNA; DEOXYRIBONUCLEASE I; DNA B; DOUBLE STRANDED DNA; INTERCALATING AGENT; NAPHTHALENE DERIVATIVE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; BINDING AFFINITY; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA FOOTPRINTING; DNA SEQUENCE; DNA TRANSCRIPTION; DRUG BINDING SITE; DRUG DNA BINDING; GC RICH SEQUENCE; INTERCALATION COMPLEX; NONHUMAN; PROTEIN DNA BINDING; ULTRAVIOLET SPECTROSCOPY; VISCOMETRY;

ANIMALS; BASE PAIRING; BINDING SITES; CATTLE; CIRCULAR DICHROISM; DNA; DNA FOOTPRINTING; GC RICH SEQUENCE; IMIDES; INTERCALATING AGENTS; NAPHTHALENES; PEPTIDES; SPECTROPHOTOMETRY, ULTRAVIOLET; VISCOSITY;

EID: 0035001274     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00335-7     Document Type: Article

References (26)

1. Dervan P.B. Science. 232:1986;464.
2. Lokey R.S., Kwok Y., Guelev V., Pursell C.J., Hurley L.H., Iverson B.I. J. Am. Chem. Soc. 119:1997;7202.
3. Trauger J.W., Baird E.E., Dervan P.B. J. Am. Chem. Soc. 120:1998;3534.
4. Turner J.M., Swalley S.E., Baird E.E., Dervan P.B. J. Am. Chem. Soc. 120:1998;6219.
5. Walker W.L., Kopka M.L., Goodsell D.S. Biopolymers. 44:1998;323.
6. Leng F., Priebe W., Chaires J.B. Biochemistry. 37:1998;1743.
7. Wakelin L.P.G. Med. Res. Rev. 6:1986;275.
8. Waring, M. J. In Molecular Aspects of Anticancer Drug-DNA Interactions; Niedle, S., Waring, M. J., Eds.; CRC: Boca Raton, 1993; Vol. 1, Chapter 7.
9. Chaires J.B. Curr. Opin. Struct. Biol. 8:1998;314.
10. Bailly C., Braña M., Waring M.J. Eur. J. Biochem. 240:1996;195.
11. Perez J.M., Lopez-Solera I., Montero E.I. Jr. J. Med. Chem. 42:1999;5482.
12. Denny W.A., Atwell G.J., Willmott G.A., Wakelin L.P.G. Biophys. Chem. 22:1985;17.
13. Onfelt B., Lincoln P., Norden B. J. Am. Chem. Soc. 121:1999;10846.
14. Laugaa P., Markovitz J., Delbarre A., Le Pecq J., Roques B.P. Biochemistry. 24:1985;5567.
15. Takenaka S., Nishira S., Tahara K., Kondo H., Takagi M. Supramol. Chem. 2:1993;41.
16. Yen S., Gabbay E.J., Wilson W.D. Biochemistry. 21:1982;2070.
17. Guelev V.M., Harting M.T., Lokey R.S., Iverson B.L. Chem. Biol. 7:2000;1.
18. Steullet V., Dixon D.W. J. Chem. Soc. Perkin Trans 2. 7:1999;1547.
19. Cohen G., Eisenberg H. Biopolymers. 8:1969;45.
20. Ren J., Chaires J.B. Biochemistry. 38:2000;16067.
21. Crothers D.M. Biopolymers. 6:1968;575.
22. Jencks W.P. Proc. Natl. Acad. Sci. U.S.A. 78:1981;4046.
23. Interestingly, other designed bis-intercalating systems with flexible linkers generally diaplay lower binding than expected as well. See, for example: Dervan P.B., Becker M.M. J. Am. Chem. Soc. 100:1978;1968.
24. Leng F., Priebe W., Chaires J.B. Biochemistry. 37:1998;1743.
25. Chaires J.B. Anti-Cancer Drug Des. 11:1996;569.
26. Novatny J., Bruccoleri R.E., Saul F.A. Biochemistry. 28:1989;4735.